adalimumab vs amlodipine
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of adalimumab and amlodipine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Humira
Norvasc
Idacio is a medicine that blocks a protein called TNF. It is used to treat several diseases, including arthritis and Crohn's disease.
Amlodipine (Norvasc) is a drug that lowers blood pressure and treats chest pain. It belongs to a class of drugs called calcium channel blockers.
Idacio can help adults with rheumatoid arthritis by reducing joint pain and damage. It can also help children (2 years and older) with juvenile idiopathic arthritis. Idacio treats psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis.
This medicine treats high blood pressure (hypertension). Lowering blood pressure reduces the risk of strokes and heart attacks. Amlodipine also treats chest pain (angina) caused by coronary artery disease, including chronic stable angina and vasospastic angina.
Idacio works by blocking a protein in your body called tumor necrosis factor (TNF). TNF can cause inflammation and damage in certain diseases. By blocking TNF, Idacio can reduce these symptoms.
Amlodipine blocks calcium from entering heart and blood vessel cells. This relaxes and widens blood vessels, making it easier for blood to flow. As a result, the heart does not have to work as hard, which lowers blood pressure and reduces chest pain.
- • Infections (like colds or sinus infections)
- • Injection site reactions (redness, itching, pain, or swelling)
- • Headache
- • Rash
- • Swelling in your ankles or feet
- • Dizziness
- • Flushing (redness of the face)
- • Palpitations (feeling your heart beat rapidly or irregularly)
- • Fatigue (feeling tired)
- Pain 49,062
- Arthralgia 48,039
- Injection Site Pain 47,251
- Fatigue 39,111
- Rheumatoid Arthritis 35,573
- Fatigue 15,697
- Diarrhoea 14,039
- Nausea 13,425
- Dyspnoea 13,218
- Dizziness 10,671
Idacio can increase your risk of serious infections that could lead to hospitalization or death. Tell your doctor if you have any infections before starting Idacio. Idacio may also increase your risk of certain cancers, including lymphoma. Children and teens taking TNF blockers like Idacio have developed rare, aggressive cancers.
Amlodipine may cause low blood pressure, especially if you have severe aortic stenosis. Some people with severe heart disease may experience worsening chest pain or a heart attack when starting or increasing the dose of amlodipine. If you have severe liver problems, your doctor will increase your dose slowly.
Tell your doctor if you are pregnant or plan to become pregnant. Idacio can cross the placenta and may affect your baby's immune system. Talk to your doctor about vaccines for your baby if you took Idacio during pregnancy.
Tell your doctor if you are pregnant or plan to become pregnant. High blood pressure during pregnancy can harm both the mother and the baby. Amlodipine passes into breast milk, but no harmful effects on the breastfed infant have been seen.
Also Compare, Nearby Drugs
Compare adalimumab with
Compare amlodipine with
How to Read This adalimumab vs amlodipine Comparison
adalimumab is classified in the TNF-Alpha Inhibitor (Biologic) drug class, while amlodipine sits within the Calcium Channel Blocker class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adalimumab has 219,036 submissions while amlodipine has 67,050. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for adalimumab or amlodipine.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.